Bispecific Nanosystems Enable Multieffector Immune Cell Retargeting for Hematologic Malignancy Therapy
Advanced Science, vol. 12, pp. e09103
Abstract
B-cell lymphomas are hematologic malignancies characterized by poor prognoses. Immunotherapy has revolutionized B-cell lymphoma treatment by harnessing immune effector cells, but current therapeutic strategies face limitations: suboptimal pharmacokinetics of bispecific antibodies and high complexity and cost of chimeric antigen receptor T-cell therapies. To address these challenges, a bispecific nanosystem (biHSNPs) is developed that exploits the multi-functional customizability of silica nanoplatform to conjugate antibodies targeting cytotoxic T cells or natural killer cells, alongside effector antibodies specific to B-cells. Four biHSNPs with different effector and target antibodies are synthesized. This bispecific nanosystem enables simultaneous binding to immune effector cells and B-cell lymphoma antigens, facilitating the formation of artificial immunological synapses. These synapses promote immune effector cell activation, leading to the release of cytotoxic proteins, while concurrently suppressing tumor cell proliferation and enhancing T-cell activation. In vivo, biHSNPs effectively suppress tumor growth and activate T cells in a xenograft mouse model, showcasing their potential in precision therapy. Moreover, biHSNPs successfully overcome tumor immune evasion through dual-target signal blockade. Using a straightforward and scalable strategy, a bispecific nanosystem is constructed that not only addresses the limitations of current bispecific antibody therapies but also represents a promising approach for the treatment of hematological malignancies.
Authors 12
-
Tianjin University · Capital Medical University · Beijing Friendship Hospital
Affiliation as printed
Department of Thoracic Surgery Beijing Friendship Hospital Capital Medical University Beijing 100050 China
School of Pharmaceutical Science and Technology Faculty of Medicine Tianjin University Tianjin 300072 China
Department of Thoracic Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050 China
School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, 300072 China
-
Xin Li corresponding
Affiliation as printed
Department of Biomedical Engineering City University of Hong Kong Hong Kong 999077 China
Department of Biomedical Engineering, City University of Hong Kong, Hong Kong, 999077 China
-
RWTH Aachen University · Academy of Military Medical Sciences
Affiliation as printed
Institute of Technical and Macromolecular Chemistry RWTH Aachen University 52074 Aachen Germany
State Key Laboratory of Pathogen and Biosecurity Academy of Military Medical Sciences Beijing 100071 China
Institute of Technical and Macromolecular Chemistry, RWTH Aachen University, 52074 Aachen, Germany
State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 100071 China
-
Affiliation as printed
School of Pharmaceutical Science and Technology Faculty of Medicine Tianjin University Tianjin 300072 China
School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, 300072 China
-
Affiliation as printed
Department I of Internal Medicine University of Cologne 50937 Köln Germany
-
Affiliation as printed
National Centre for International Research in Cell and Gene Therapy Sino‐British Research Centre for Molecular Oncology State Key Laboratory of Esophageal Cancer Prevention & Treatment School of Basic Medical Sciences Academy of Medical Sciences Zhengzhou University Zhengzhou 450001 China
National Centre for International Research in Cell and Gene Therapy, Sino-British Research Centre for Molecular Oncology, State Key Laboratory of Esophageal Cancer Prevention & Treatment, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, 450001 China
-
Queen Mary University of London · Barts Cancer Institute
Affiliation as printed
Centre for Cancer Biomarkers & Biotherapeutics Barts Cancer Institute Queen Mary University of London London EC1M 6BQ UK
Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ UK
-
Affiliation as printed
Ningbo Dilato Materials Co., LTD 581 South Zhuangyu Road, Zhenhai District Ningbo 315200 China
Ningbo Dilato Materials Co., LTD, 581 South Zhuangyu Road, Zhenhai District, Ningbo, 315200 China
-
Affiliation as printed
Institute of Cardiovascular Sciences Guangxi Academy of Medical Sciences Nanning 530021 China
Institute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences, Nanning, 530021 China
-
Academy of Military Medical Sciences
Affiliation as printed
State Key Laboratory of Pathogen and Biosecurity Academy of Military Medical Sciences Beijing 100071 China
State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 100071 China
-
Xiuyun Liu corresponding
Affiliation as printed
Neurocritical Care Medicine Innovation Center Ministry of Education Tianjin University Tianjin 300072 China
School of Pharmaceutical Science and Technology Faculty of Medicine Tianjin University Tianjin 300072 China
Neurocritical Care Medicine Innovation Center, Ministry of Education, Tianjin University, Tianjin, 300072 China
-
Zhiyuan Shi corresponding
University of Cologne · Tianjin University
Affiliation as printed
Department I of Internal Medicine University of Cologne 50937 Köln Germany
School of Pharmaceutical Science and Technology Faculty of Medicine Tianjin University Tianjin 300072 China
School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, 300072 China
Cited by 3 stored of 3
3 results
No patents citing this paper on Lens.org (checked 2026-10-06).
References 54
-
W2903686952details pending0citations
-
W2026496528details pending0citations
-
W1966128754details pending0citations
-
W2563976031details pending0citations
-
W2043228552details pending0citations
-
W2084659308details pending0citations
-
W1982320535details pending0citations